Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Market Cap	1.85B
Revenue (ttm)	1.16B
Net Income (ttm)	605.05M
Shares Out	1.50B
EPS (ttm)	0.40
PE Ratio	3.05
Forward PE	n/a
Dividend	0.08 (6.61%)
Ex-Dividend Date	n/a

Volume	28,000
Average Volume	176,600
Open	1.230
Previous Close	1.230
Day's Range	1.220 - 1.230
52-Week Range	1.090 - 1.400
Beta	0.64
RSI	63.58
Earnings Date	Mar 21, 2025

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 1,143
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2348

Financial Performance

In 2023, HKG:2348's revenue was 1.15 billion, a decrease of -9.90% compared to the previous year's 1.28 billion. Earnings were 326.00 million, a decrease of -8.95%.

Financial numbers in CNY